The Medicines and Healthcare products Regulatory Agency said the manufacturer is recalling specific batches
Patients have been instructed to return certain batches of paracetamol due to contamination concerns, according to an announcement made today. The Medicines and Healthcare products Regulatory Agency (MHRA) stated that Chelonia Healthcare Limited, the manufacturer, is recalling specific batches of Paracetamol 500mg Tablets (100 pots) as a precautionary measure.
The recall is reportedly “due to contamination following a small number of complaints of discoloured tablets within the pots.”
The alert advised: “Patients or carers should check to see if they have received tablets from the listed batches of Paracetamol 500 mg Tablets. The batch number can be found on the label of the medicine bottle and on the outer carton.
“These tablets can only be obtained from a pharmacy with a prescription. The number of tablets you will have been given will vary depending on your prescription and you may have only received a small number of tablets.”
Medicine Details
Paracetamol 500mg Tablets
PL: 33414/0126
Active ingredient: Paracetamol
SNOMED code: 33554711000001108
GTIN: 05060014445506
Affected Lot Batch Numbers
Batch No.
The statement further added: “The tablets should be ‘white capsule-shaped tablets, scored on one side’, as per the Patient Information Leaflet (PIL). If you find tablets that are discoloured in any way, in pots from the listed batches, please contact your pharmacist or the healthcare professional who dispensed your prescription.
“Patients who experience adverse reactions or have any questions about the medication, should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.”
The MHRA has categorised the recall as Class 2, indicating that while the defect could lead to mistreatment or harm, it is not considered life-threatening or serious. Pharmacists have received clear instructions: “Stop supplying the above batches immediately. Quarantine all remaining stock and return it to your supplier, using your supplier’s approved process.”
For further details, click here.